Month: September 2023

If you have type 2 diabetes, you may have heard of Xultophy, a combination medication that contains two active substances: insulin degludec and liraglutide. These

Cystic fibrosis (CF) is a genetic disorder that affects the lungs and other organs. It causes thick and sticky mucus to build up in the

Actemra (Tocilizumab) is a monoclonal antibody that blocks the action of interleukin-6 (IL-6), a cytokine that plays a key role in inflammation and immune response.

SMA is caused by mutations in the SMN1 gene, which normally produces SMN protein. Without enough SMN protein, motor neurons die and muscles weaken over

Remdesivir (Veklury) is a broad-spectrum antiviral medication that has been approved or authorized for emergency use to treat COVID-19 in many countries. It is administered

In a major breakthrough in the fight against COVID-19, the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for bamlanivimab,

Diabetes is a chronic condition that affects millions of people worldwide. It is characterized by high blood glucose levels due to insufficient insulin production or

Vildagliptin (Galvus) is a medication that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is used to treat type 2 diabetes mellitus, a

Multiple myeloma is a type of blood cancer that affects plasma cells, which are a type of white blood cell that produce antibodies. In multiple

Denosumab is a type of targeted therapy called a monoclonal antibody. It is made in the laboratory to recognise and find specific proteins on the